These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19224930)

  • 21. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
    Cantin B; Després JP; Lamarche B; Moorjani S; Lupien PJ; Bogaty P; Bergeron J; Dagenais GR
    Am J Cardiol; 2002 Mar; 89(6):662-6. PubMed ID: 11897206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity.
    Li Z; Deng ML; Tseng CH; Heber D
    Metab Syndr Relat Disord; 2013 Apr; 11(2):87-91. PubMed ID: 23259588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen and associated risk factors in a high-risk population: urban Indigenous Australians, the DRUID Study.
    Maple-Brown LJ; Cunningham J; Nandi N; Hodge A; O'Dea K
    Cardiovasc Diabetol; 2010 Oct; 9():69. PubMed ID: 21029470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal and total adiposity and risk of coronary heart disease in men.
    Rexrode KM; Buring JE; Manson JE
    Int J Obes Relat Metab Disord; 2001 Jul; 25(7):1047-56. PubMed ID: 11443505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study).
    Côté M; Cartier A; Reuwer AQ; Arsenault BJ; Lemieux I; Després JP; Wareham NJ; Kastelein JJ; Boekholdt SM; Khaw KT
    Am J Cardiol; 2011 Aug; 108(3):367-73. PubMed ID: 21550577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
    Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
    Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity.
    Abdou AS; Magour GM; Mahmoud MM
    Br J Biomed Sci; 2009; 66(3):143-7. PubMed ID: 19839225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
    Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
    J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes.
    Hatoum IJ; Hu FB; Nelson JJ; Rimm EB
    Diabetes; 2010 May; 59(5):1239-43. PubMed ID: 20185811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abdominal obesity with hypertriglyceridaemia, lipoprotein(a) and apolipoprotein A-I determine marked cardiometabolic risk.
    Onat A; Can G; Örnek E; Sansoy V; Aydın M; Yüksel H
    Eur J Clin Invest; 2013 Nov; 43(11):1129-39. PubMed ID: 24020867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters.
    Wannamethee SG; Tchernova J; Whincup P; Lowe GD; Rumley A; Brown K; Cherry L; Sattar N
    Int J Obes (Lond); 2007 Jul; 31(7):1089-98. PubMed ID: 17264850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Sarno MJ; Bettencourt R; Wolfert RL; Barrett-Connor E
    J Am Coll Cardiol; 2008 Mar; 51(9):913-9. PubMed ID: 18308160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk.
    Onat A; Avci GS; Barlan MM; Uyarel H; Uzunlar B; Sansoy V
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1018-25. PubMed ID: 15197408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study.
    van Wijk DF; Boekholdt SM; Arsenault BJ; Ahmadi-Abhari S; Wareham NJ; Stroes ES; Khaw KT
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27260511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.
    Kuller LH; Grandits G; Cohen JD; Neaton JD; Prineas R;
    Atherosclerosis; 2007 Nov; 195(1):122-8. PubMed ID: 17011566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.
    Klüppelholz B; Thorand B; Koenig W; de Las Heras Gala T; Meisinger C; Huth C; Giani G; Franks PW; Roden M; Rathmann W; Peters A; Herder C
    Diabetologia; 2015 Oct; 58(10):2269-77. PubMed ID: 26155746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
    Packard CJ; O'Reilly DS; Caslake MJ; McMahon AD; Ford I; Cooney J; Macphee CH; Suckling KE; Krishna M; Wilkinson FE; Rumley A; Lowe GD
    N Engl J Med; 2000 Oct; 343(16):1148-55. PubMed ID: 11036120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.